Chart: PARTNER II: Ready To Launch
This article was originally published in The Gray Sheet
Executive Summary
Following well-received one-year results from its PARTNER study, Edwards announced Sept. 23 that it has finally received FDA go-ahead to begin the U.S. pivotal trial of its next-generation Sapien XT transcatheter valve.